CDSCO panel gives nod for continuation of phase-II clinical trial of SII’s dengue vaccine
New Delhi: An expert committee under the Central Drug Regulatory Authority has recommended continuation of phase II clinical trial of the Serum Institute Of India (SII)’s vaccine against dengue after…
SII Manufactures First Batch Of Covavax Vaccine; Poonawalla Congratulates Team
New Delhi: Serum Institute of India (SII) chief Adar Poonwalla on Friday announced that the SII has manufactured the first batch of the Covavax vaccine. He said that this vaccine…
Pune: Five Die In Fire At Serum Plant, Covishield Unit Not Affected
PUNE : Five workers were killed in a major fire that broke out at Serum Institute of India’s (SII) vaccine manufacturing plant at Manjari near Hadapsar here around 2.30pm on Thursday.…
India will have happy New Year with vaccine in hand: DCGI
The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel…
